Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue.
about
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical useMain Properties of the THERAFLEX MB-Plasma System for Pathogen ReductionPlasma components: properties, differences, and uses.Approach of using established and new laboratory tests to more comprehensively investigate noninfectious and nonhemolytic transfusion reactions--along with the experience in Japan.Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?Component pathogen inactivation: a critical review.Adverse effects of plasma transfusionCurrent understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment.Proteomics of blood and derived products: what's next?Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?Update on the use of pathogen-reduced human plasma and platelet concentrates.Red cell transfusion and the immune system.The role of hemovigilance and postmarketing studies when introducing innovation into transfusion medicine practice: the amotosalen-ultraviolet A pathogen reduction treatment model.A regional haemovigilance retrospective study of four types of therapeutic plasma in a ten-year survey period in France.Clinical utility of a passive immune basophil activation test for the analysis of allergic transfusion reactions.Detection of specific immunoglobulin E antibodies toward common airborne allergens, peanut, wheat, and latex in solvent/detergent-treated pooled plasma.
P2860
Q26741073-3F8C1D36-3541-4371-8731-9DF0050810FFQ33396311-06FF45E0-C83D-4BB0-AF4C-CECE9D5EBFB7Q33401173-75DE6E5D-ABBC-4985-8953-B7A35E5B3E8AQ33408363-BF40516C-64E3-4D12-8148-11A47E43FD5AQ33841435-91DBD5B6-6323-40DC-B591-434B1123D7F3Q34310415-05F9D1E0-A1CF-43DF-A9DB-97825822A52FQ35972184-B5247946-EDBD-443C-B05C-CD94FFB664D5Q36676742-6C9B9E1C-2201-4FC1-9228-3A0864460D07Q37956664-E7BE6F5B-97CB-42C4-92B6-C0B004C6B582Q37959053-425DB139-D67C-4A25-B3A3-45437AA3B785Q37975604-A6A9208C-944B-4668-A1F7-61AAC93BB4B2Q38109665-4273D6FF-9F2F-4E32-BE23-2110290AF78EQ38273784-2BAB0D2B-37A0-4E8B-A6A8-9E90639DCA7BQ38784176-4CBFD5EC-595A-43EC-9F8E-F1221B806B6BQ43779317-1BA20492-211D-4D1B-9D01-8267E6F105BEQ50203875-FD46C8DE-3EB1-454E-9818-90312366EBB7Q50268580-5BB725D4-815F-439B-A687-0CAC669922D9
P2860
Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue.
@en
Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue.
@nl
type
label
Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue.
@en
Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue.
@nl
prefLabel
Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue.
@en
Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue.
@nl
P2093
P2860
P1433
P1476
Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue.
@en
P2093
Isabelle Orsel
Jean Sainte Laudy
Karine Nubret
Martine Delhoume
Mohamed Sellami
Nathalie Nathan
P2860
P304
P356
10.1111/J.1537-2995.2010.02800.X
P577
2011-01-01T00:00:00Z